Bohlin Garen G
CIK 0001254705
Director
Filings
12
Latest May 26, 2026
Issuers covered
2
Showing
12 of 12
Page 1
Track record
2 of 3 open-market trades scored (67% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | +0.5% | +0.5% | +4.0% | -3.1% |
| 90 days | 2 | 0% | -23.3% | -23.3% | -7.0% | -39.7% |
| 180 days | 2 | 100% | +9.0% | +9.0% | +14.7% | +3.3% |
| 365 days | 2 | 50% | -15.2% | -15.2% | +12.7% | -43.0% |
Issuers
Companies where Bohlin Garen G has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| COLL | Collegium Pharmaceutical, Inc | 6 | May 18, 2026 |
| KPTI | Karyopharm Therapeutics Inc. | 6 | May 26, 2026 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|